Cellular Responses to the Membrane Attack Complex

[1]  H. Rus,et al.  Sublytic complement attack induces cell cycle in oligodendrocytes. , 1996, Journal of immunology.

[2]  C. Alpers,et al.  Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. , 1996, Kidney international.

[3]  J. Platt,et al.  Complement-mediated regulation of tissue factor activity in endothelium , 1995, The Journal of experimental medicine.

[4]  P. Sims,et al.  Induction of cellular procoagulant activity by the membrane attack complex of complement. , 1995, Seminars in cell biology.

[5]  L. Matis,et al.  Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Whorton,et al.  S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. , 1995, The American journal of physiology.

[7]  Z. Fishelson,et al.  Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis. , 1995, Journal of immunology.

[8]  B. Morgan,et al.  Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack. , 1995, Immunology.

[9]  L. Mahadevan,et al.  Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.

[10]  C. Mold,et al.  Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. , 1994, Journal of immunology.

[11]  J. Schofer,et al.  Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. , 1994, European heart journal.

[12]  J. Halperin,et al.  Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells , 1994, The Journal of experimental medicine.

[13]  A. F. Esser,et al.  The membrane attack complex of complement. Assembly, structure and cytotoxic activity. , 1994, Toxicology.

[14]  H. Rus,et al.  Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. , 1994, The Journal of biological chemistry.

[15]  G. Hänsch,et al.  Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. , 1994, Experimental nephrology.

[16]  F. Moore.  Therapeutic regulation of the complement system in acute injury states. , 1994, Advances in immunology.

[17]  M. Hallett,et al.  Cross‐linking of CD59 and of other glycosyl phosphatidylinositol‐anchored molecules on neutrophils triggers cell activation via tyrosine kinase , 1993, European journal of immunology.

[18]  H. Rus,et al.  Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. , 1993, Journal of immunology.

[19]  J. Halperin,et al.  Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. , 1993, The Journal of clinical investigation.

[20]  P. Sims,et al.  Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. , 1993, The Journal of biological chemistry.

[21]  B. Jahn,et al.  Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA. , 1993, Immunology.

[22]  H. Rus,et al.  Generation of diacylglycerol and ceramide during homologous complement activation. , 1993, Journal of immunology.

[23]  T. Ortel,et al.  Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. , 1993, Blood.

[24]  S. J. Elliott,et al.  The contribution of increased collagen synthesis to human glomerulosclerosis: a quantitative analysis of alpha 2IV collagen mRNA expression by competitive polymerase chain reaction , 1992, The Journal of experimental medicine.

[25]  Z. Fishelson,et al.  Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP). , 1992, Molecular immunology.

[26]  Z. Fishelson,et al.  Sublytic complement attack protects tumor cells from lytic doses of antibody and complement , 1992, European journal of immunology.

[27]  P. Ward,et al.  Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. , 1992, Journal of immunology.

[28]  B. Morgan.  Effects of the membrane attack complex of complement on nucleated cells. , 1992, Current topics in microbiology and immunology.

[29]  W. Rosse,et al.  Paroxysmal nocturnal hemoglobinuria. , 1992, Current topics in microbiology and immunology.

[30]  S. Ruddy,et al.  Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[31]  P. Sims,et al.  Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. , 1991, Blood.

[32]  P. Sims,et al.  The response of human platelets to activated components of the complement system. , 1991, Immunology today.

[33]  A. F. Esser.  Big MAC attack: complement proteins cause leaky patches. , 1991, Immunology today.

[34]  S Bhakdi,et al.  Complement lysis: a hole is a hole. , 1991, Immunology today.

[35]  C. Koski,et al.  In vitro demyelination by serum antibody from patients with guillain‐barré syndrome requires terminal complement complexes , 1991, Annals of neurology.

[36]  J. Luzio,et al.  Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles. , 1991, The Biochemical journal.

[37]  J. Volanakis,et al.  Molecular genetics, structure, and function of C-reactive protein , 1991, Immunologic research.

[38]  J. Dankert,et al.  Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. , 1990, Journal of Immunology.

[39]  S. Meri,et al.  Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. , 1990, Immunology.

[40]  M. Shin,et al.  Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. , 1990, Journal of immunology.

[41]  P. Sims,et al.  The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. , 1990, Journal of immunology.

[42]  G. Moretto,et al.  Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. , 1990, The New England journal of medicine.

[43]  C. Esmon,et al.  Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. , 1990, The Journal of biological chemistry.

[44]  J. Luzio,et al.  Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity. , 1990, Biochemistry.

[45]  B. W. van der Meer,et al.  Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids. , 1989, Biophysical journal.

[46]  S. Binder,et al.  Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. , 1989, Journal of immunology.

[47]  P. Sims,et al.  Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. , 1989, The Journal of biological chemistry.

[48]  A. Campbell,et al.  Normal rat serum cytotoxicity against syngeneic oligodendrocytes Complement activation and attack in the absence of anti-myelin antibodies , 1989, Journal of the Neurological Sciences.

[49]  P. Sims,et al.  The secretory release reaction initiated by complement proteins C5b-9 occurs without platelet aggregation through glycoprotein IIb-IIIa. , 1989, Blood.

[50]  B. Morgan,et al.  In vivo and in vitro evidence of cell recovery from complement attack in rheumatoid synovium. , 1988, Clinical and experimental immunology.

[51]  M. Shin,et al.  Hydrolysis of myelin basic protein in human myelin by terminal complement complexes. , 1988, The Journal of biological chemistry.

[52]  P. Sims,et al.  Complement C5b-9-stimulated platelet secretion is associated with a Ca2+-initiated activation of cellular protein kinases. , 1987, The Journal of biological chemistry.

[53]  E. Ritz,et al.  Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. , 1987, Kidney international.

[54]  J. Dankert,et al.  Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. , 1987, Journal of immunology.

[55]  M. Betz,et al.  Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. , 1987, International archives of allergy and applied immunology.

[56]  W. Seeger,et al.  Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. , 1986, Journal of immunology.

[57]  P. Sims,et al.  Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++ -dependent exocytotic elimination of C5b-9 pores , 1986 .

[58]  M. Shin,et al.  Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+. , 1986, Journal of immunology.

[59]  H. Rus,et al.  Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. , 1986, Atherosclerosis.

[60]  J. Dankert,et al.  Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis. , 1986, Journal of immunology.

[61]  A. Campbell,et al.  The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium. , 1985, The Biochemical journal.

[62]  A. Campbell,et al.  Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack , 1985, Nature.

[63]  M. Shin,et al.  Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. , 1985, Journal of immunology.

[64]  B. Morgan,et al.  2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocytes attacked by complement. , 1985, Biochemical and biophysical research communications.

[65]  M. Betz,et al.  Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. , 1984, Journal of immunology.

[66]  M. Shin,et al.  Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate. , 1983, Journal of immunology.

[67]  S. Bhakdi,et al.  Membrane damage by complement. , 1983, Biochimica et biophysica acta.

[68]  M. Shin,et al.  Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[69]  T. Takenawa,et al.  Role of Ca2+ in phosphatidylinositol response and arachidonic acid release in formylated tripeptide- or Ca2+ ionophore A23187-stimulated guinea pig neutrophils. , 1983, Journal of immunology.

[70]  L. McManus,et al.  Complement localization in ischemic baboon myocardium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[71]  M. Shin,et al.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[72]  N. Day,et al.  Antibody-independent complement activation by myelin via the classical complement pathway , 1982, The Journal of experimental medicine.

[73]  D. Koffler,et al.  Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis , 1981, The Journal of experimental medicine.

[74]  R. Levine,et al.  How complement kills E. coli. I. Location of the lethal lesion. , 1981, Journal of immunology.

[75]  M. Polley,et al.  The human complement system in thrombin-mediated platelet function , 1978, The Journal of experimental medicine.

[76]  H. Müller-Eberhard,et al.  A BLOOD COAGULATION ABNORMALITY IN RABBITS DEFICIENT IN THE SIXTH COMPONENT OF COMPLEMENT (C6) AND ITS CORRECTION BY PURIFIED C6 , 1971, The Journal of experimental medicine.

[77]  H. Green,et al.  THE ACTION OF ANTIBODY AND COMPLEMENT ON MAMMALIAN CELLS * , 1960, Annals of the New York Academy of Sciences.

[78]  H. Green,et al.  EFFECT OF ANTIBODY AND COMPLEMENT ON PERMEABILITY CONTROL IN ASCITES TUMOR CELLS AND ERYTHROCYTES , 1959, The Journal of experimental medicine.